Pricing Log in Create free account

BioLineRx Ltd. (BLRX) vs Moleculin Biotech, Inc. (MBRX)

BioLineRx Ltd. and Moleculin Biotech, Inc. are both Biotechnology companies. BioLineRx Ltd. and Moleculin Biotech, Inc. are of similar size ($9.2M and $8.8M). BioLineRx Ltd. has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.0×. Moleculin Biotech, Inc. has the higher net margin (0.00% vs −502.1%) and the lower return on invested capital (−417.3% vs −74.3%). Across the 14 metrics below, BioLineRx Ltd. leads on 7 and Moleculin Biotech, Inc. on 7.

Valuation

Metric BLRX MBRX Biotechnology median
P/E n/m 0.04 10.26
P/S 5.65 n/m 9.18
P/B 0.47 0.21 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.16 0.65
EV/Sales 1.06 n/m 8.98
Earnings yield (90.47%) 2,573.95% (34.89%)
Free cash flow yield (137.86%) (1,027.71%) (24.52%)

Profitability

Metric BLRX MBRX Biotechnology median
Gross margin 80.03% 0.00% 65.16%
Operating margin (874.28%) 0.00% 0.00%
Net margin (502.08%) 0.00% 0.00%
Free cash flow margin (776.29%) 0.00% 0.00%
Return on equity (38.10%) (1,471.05%) (50.12%)
Return on assets (18.21%) (152.41%) (45.60%)
Return on invested capital (74.28%) (417.27%) 0.00%

Growth

Metric BLRX MBRX Biotechnology median
Revenue growth (TTM) (91.93%) — 6.26%
EPS growth (last fiscal year) 93.72% 82.01% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLRX MBRX Biotechnology median
Debt to equity 0.40 0.00 0.00
Current ratio 1.20 0.94 4.89
Net debt to EBITDA 1.22 0.35 1.01

Dividend

Metric BLRX MBRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BLRX MBRX Biotechnology median
Market cap 8.80m 9.16m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack